Impact of policy changes on the provision of naloxone by pharmacies in Ontario, Canada: a population‐based time–series analysis

BACKGROUND AND AIMS: In June 2016, the Ontario, Canada government implemented the Ontario Naloxone Program for Pharmacies (ONPP), authorizing pharmacists to provide injectable naloxone kits at no charge to all Ontario residents. In March 2018, the program was amended to include intranasal naloxone a...

Descripción completa

Detalles Bibliográficos
Autores principales: Antoniou, Tony, Martins, Diana, Campbell, Tonya, Tadrous, Mina, Munro, Charlotte, Leece, Pamela, Mamdani, Muhammad, Juurlink, David N., Gomes, Tara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247272/
https://www.ncbi.nlm.nih.gov/pubmed/33207025
http://dx.doi.org/10.1111/add.15324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247272/
https://www.ncbi.nlm.nih.gov/pubmed/33207025
http://dx.doi.org/10.1111/add.15324

Ejemplares similares